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Several of the naturally occurring autoimmune diseases have experimental
correlates induced in laboratory animals by immunization with specific compo-
nents of the target organ (1-3) . The ensuing disease is proof that self-reactive
cells are not always deleted from the repertoire, but circulateand can be activated
in the periphery . Among those inducible diseases believed to be T cell mediated,
it has been observed that clinical and histological symptoms of disease are
sometimes more easily induced with heterologous antigen than with the homol-
ogous self-antigen (4-7) . Studies on the specificity of the resulting autoimmune
T cell populations indicate a concordantly higher degree of responsiveness to
the heterologous antigens than to the self-antigen (8, 9) . This lends support to
the hypothesis that the autoreactive T cells that escape from the thymus and
circulate in the periphery have a relatively low affinity for self and therefore
may not be activated by physiological levels of self-antigen, although they may
exhibit higher affinities for closely related non-self antigens .
We have investigated the T cell response of Lewis rats to the autoantigen
myelin basic protein (MBP) .' Immunization with a single injection of MBP in
CFA produces an acute episode ofexperimental allergic encephalomyelitis (EAE),
characterized histologically by infiltration of the central nervous system with Ia+
mononuclear cells and T cells of the helper phenotype (10, 11), and clinically by
an ascending paralysis of the fore and hind limbs . The disease has been shown
to be T cell mediated, without dependence on B cells or antibody (12-14), and
can be induced more easily with guinea pig (GP) MBP than with autologous rat
MBP (6, 7) . This result has been explained in previous studies as a rat MBP-
induced T cell population that exhibits a heteroclitic response for the major
encephalitogenic determinant of GP MBP, amino acid residues 68-88 (8) . We
generated cloned T cell hybridomas from both rat and GP MBP-immunized
animals to assess the degree of heterocliticity as related to the above hypothesis .
We report here an unpredicted subpopulation of T cells that are reactive
equally to GP and rat MBP and the 68-88 peptide, appearing more frequently
in rat MBP-immunized animals than in GP MBP-immunized animals, and
proving that not all self-reactive clones exhibit poor reactivity to self. Moreover,
This work was supported by grants from the National Multiple Sclerosis Society (NMS RG1593A-1)
and the U. S . Public Health Service (NS-11036) .
' Abbreviations used in this paper;
￿
EAE, experimental allergic encephalomyelitis ; GP, guinea pig ;
MBP, myelin basic protein ; PEG, polyethylene glycol ; PPD, purified protein derivative of tuberculin .
502
￿
,] . Exp . MED. © The Rockefeller University Press - 0022-1007/88/02/0502/12$2.00
Volume 167
￿
February 1988 502-513HAPP AND HEBER-KATZ
￿
503
we observed that immunization with rat as opposed to GP MBP induced a
different population of responding T cells, most notably an encephalitogenic
subpopulation specific for non-68-88 regions of MBP. Surprisingly, all of the
clones induced by rat MBP demonstrated equal reactivity to GP and rat MBPs.
Taken together, these results do not support the notion that rat MBP is poorly
encephalitogenic because the responding T cells exhibit relatively low sensitivity
to the self antigen. Rather, they indicate that the T cell responses to self (rat
MBP) and to non-self (GP MBP) antigens may be subject to different immuno-
regulatory forces in the immunized animal.
Materials and Methods
Animals.
￿
Female Lewis rats were obtained from Charles RiverBreeding Laboratories,
Wilmington, MA. All rats were housed at The Wistar Institute animal facility and were
used at 2-5 mo of age.
Antigen.
￿
MBP was obtained from the spinal cords of GP and brains of rabbits and
Lewis rats (rat MBP) by a modification of the method of Diebler as previously described
(Happ, M . P., B. Dietzschold, P. Wettstein, and E. Heber-Katz, submitted for publication).
Pig MBP was obtained from Calbiochem-Behring Corp., La Jolla, CA (Lot 475916). SDS-
PAGE on a linear gradient slab gel revealed a major band at 18 kD for GP, rabbit, and
pig MBPs with <5% contamination. HPLC analysis of GP MBP revealed a single sharp
peak. SDS-PAGE analysis of rat MBP revealed two major bands at 18 and 14 kD, with
the smaller band being more intense. HPLC analysis produced a single peak with a broad
base.
We prepared a 19-amino acid peptide corresponding to the 68-88 sequence of GP
MBP using the Merrifield solid-phase method as previously described (Happ, M. P., et al.,
submitted for publication). MBP fragments generated by limited pepsin digestion of GP
MBP were kindly donated by R. Fritz (Emory University School of Medicine, Atlanta,
GA) . The preparation and purity of the fragments have been previously described (16).
All MBPs and peptides were stored lyophilized, and portions were periodically reconsti-
tuted to a concentration of 1 mg/ml saline for use.
Induction ofEAE.
￿
Animals were immunized in both hind foot pads with a total of 0.2
ml of a 1 :1 emulsion of the appropriate antigen in saline and H37Ra adjuvant (Difco
Laboratories Inc., Detroit, MI), consisting of IFA supplemented with 1 .0 mg of heat-
killed and dried Mycobacterium tuberculum per milliliter of adjuvant. Thus, each rat
received a total of 100 wg of M. tuberculum. Rats were observed daily until clinical
symptoms disappeared in affected animals, or for 3-4 wk ifno clinical symptoms appeared.
Proliferation Assays. In vitro proliferation assays were performed as previously de-
scribed (Happ, M . P., et al., submitted for publication). Briefly, animals were killed I I-
13 d after immunization and their popliteal and inguinal lymph nodes were removed.
Single cell suspensions were made and passed over nylon-wool columns. The eluted cells
(90-95% T cells by FACS analysis) were placed in 96-well flat-bottomed plates at 4 X
105/well. 105 irradiated (3,000 rad) syngeneic spleen cells/well were added to serve as
APCs. The assays were pulsed at the time of peak proliferation (60-90 h) with 10 tul of
['H]TdR (at a concentration of 50,uCi/ml) per well and then harvested 14-18 h later and
counted.
The medium used was RPMI supplemented with 10 mM Hepes, 5 X 10-5 M 2-ME, 2
MM L-glutamine, 1 mM sodium pyruvate, 1% 100X vitamins for Eagle's modified MEM,
1 % 100X nonessential amino acids for Eagle's MEM, 250 pg gentamicin/ml, and 10%
FCS.
Generation ofTCell Hybridomas.
￿
Animals were killed 11-13 d after immunization with
50 Ag GP MBP or 500 jug rat MBP. The popliteal and inguinal lymph nodes were
removed, ground to single cell suspensions and washed several times with Dulbecco's PBS.
25 X 10' cells were cultured with 10' irradiated syngeneic spleen cells prepared as
described above. The cultures were supplemented with 10 kg of the immunizing anti-504
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gen/ml and were maintained in upright 25-cm' flasks in the enriched RPMI described
above. After 4 d, 2-4 X 106 blast cells were fused for 2 min to 2-4 X 106 BW5147
thymoma cellsat a ratio of 1 :2 or 2:1 using the polyethylene glycol (PEG)-mediated fusion
procedure previously described (17) and 35% PEG (vol/vol). The cells were immediately
plated in selective HAT medium to 96-well plates and observed for the appearance of
growth-positive wells. Hybrids were picked from plates with 50% or fewer growth-positive
wells and tested for the production of IL-2 in response to 50 Ag/ml of the immunizing
antigen as described below. Positive hybrids were recloned and maintained in enriched
RPMI .
T Cell Hybridoma Assays.
￿
T cell hybridomas were plated at 1-1 .5 X 104/well in 96-
well flat-bottomed plates. Antigen and 105 syngeneic spleen cells were added to each well
in enriched RPMI. After 48 h, an aliquot of the supernatant was removed to a second 96-
well plate for IL-2 quantitation . 5 X 105 HT2 cells were added to each well of the second
plate and the assay was pulsed 16-22 h later with 10 Fcl of [sH]TdR (50 uCi/ml). The
wells were harvested 8 h later and counted.
Generation of T Cell Lines and Adoptive Transfer ofEAE.
￿
Bulk cultures were prepared
as described above for fusions and were incubated for 10 d. Live cells were separated on
Ficoll-Paque (Pharmacia Fine Chemicals, Piscataway, NJ) and restimulated in 6-well plates
at 0.4 X 106 cells/ml with 1 .6 X 106 irradiated syngeneic spleen/ml and antigen in 5 ml
of enriched RPMI. 7 d later, the Ficoll separation and restimulation were repeated.
Antigen responsiveness was measured using the proliferation assay described above,
substituting 2.5 X 104 line cells/well in place of primed lymph node.
Cells were harvested and Ficoll separated for adoptive transfer 3 d after restimulation
with antigen and APC. After washing, the cells were injected in a volume of 1 .0 ml saline
into naive Lew recipients. Because we have found that lightly irradiating recipients increase
the efficiency of adoptive transfer (unpublished results), recipients were given 350 rad
whole-body irradiation immediately before transfer.
Results
Induction ofEAE.
￿
Guinea pig and rat MBPs were compared for their ability
to induce EAE in Lewis rats using adjuvant supplemented with only 100 'Ug of
M. tuberculosis. In agreement with previous reports (6, 7), GP MBP was ^-10-fold
more potent at inducing clinical symptoms of EAE than was rat MBP (Table I).
A synthetic peptide encompassing amino acid residues 68-88 of GP MBP was
found to be equivalent to the whole GP MBP on a molar basis for induction of
clinical EAE, again demonstrating that this determinant retains the encephalito-
genic potential of the whole MBP (7, 16, 18) and affirming that the peptide
preparation was a good one .
In Vitro Proliferation to MBP. After 11-13 d, lymph node cells from rats
immunized with 50 jug of GP MBP or 100 lAg of rat MBP were assayed for
proliferation in response to the various MBP antigens listed in Table II, showing
their 68-88 amino acid sequences.
Rats immunized with GP MBP responded best to GP MBP, less well to the GP
68-88 peptide and rat MBP, and minimally to rabbit and pig MBP (Fig. 1 A) .
Animals immunized with rat MBP produced the response pattern illustrated in
Fig. 1 B, although they did not always exhibit clinical symptoms at the time of
sacrifice. In contrast to the GP MBP-immunized animals, rat MBP produced
nearly equipotent responses to GP and rat MBPs, as well as significant responses
to rabbit and pig MBPs. To determine the basis for the different response
patterns elicited by the autoantigen and its more potent heterologous counter-
part, we examined the specificities of individual clones within these populations.HAPP AND HEBER-KATZ
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TABLE I
Summary ofInduction of EAE by MBP andEncephalitogenic Peptide in Lewis Rats
* Antigen was administered in 0.2 ml adjuvant containing 100 ug ofMycobacterium tuberculum.
Average day of onset indicates the average number of days ± SD before the appearance of the
first clinical symptom and excludes those animals within the group that did not develop any
symptoms within 3 wk of immunization. Those animals arealso excluded from thecalculation of
average maximum clinical symptom.
g Clinical symptoms were scored as follows: 1, floppy tail; 2, partial paralysis of the hind limbs; 3,
full paralysisof both hind limbs; 4, full paralysis of the fore andhind limbs.
TABLE II
Amino Acid Sequence of the 68-88 Region ofMBPfrom the VariousSpecies
Used to Determine Fine Specificity
MBP
￿
68
￿
7 5
￿
8 0
￿
8 5
￿
88
* * **
Rat
￿
G-S-L-P-Q-K-S -Q---- -R-T-Q-D-E-N-P-V- V-H-F
GP
￿
G-S-L-P-Q-K-S -Q---- -R-S -Q-D-E-N-P-V-V-H-F
Rabbit G-S-L-P-Q-K-S---G-H-R-P-Q-D-E-N-P-V-V-H-F
Pig G-S-L-P-Q-K-A-Q-G-H-R-P-Q-D-E-N-P-V-V-H-F
* Indicates residues displaying interspecies heterogeneity. Sequencestaken from
reference 19.
The Clonal Response to GB MBP.
￿
We generated T cell hybridomas as a source
of clonable, antigen-specific T cells, assuming that the hybridization event is a
random one and does not discriminate on the basis ofreceptor specificity. Tcell
fusion should allow cloning of weakly represented specificities that may become
lost or "overgrown" in the generation oflong-term lines. We fused bulk cultures
of GP MBP-immune lymph node cells to the BW5147 fusion partner, then
selected and cloned, from three different fusions, 30 hybridomas specific for GP
MBP. Eight of these hybridomas responded to GP MBP alone, apparently to
determinants not encoded within the 68-88 peptide (Fig. 2A). Cleavage frag-
ments of GP MBP were used to localize the antigenic determinants seen by these
clones. Two of the seven tested responded to the 43-88 fragment but not the
68-88 peptide, while the remaining five responded to none of the fragments
Antigen Dose* Number
sick/total x Day of onset*
ii Maximum
clinical
symptom$
lug nmol
GP MBP 50 2.5 16/16 11 .2 ± 0.54 3.0 ± 0
20 1.0 6/7 11 .7±0.51 3.0±0
10 0.5 5/5 13.6±0.89 2.0±0.7
5 0.25 0/7 - -
GP 68-88 20 10.0 5/5 11 .4 ± 0.54 3.0 ± 0
5 2.5 5/5 12.0±0.70 3.0±0
1 0.5 5/5 11 .8±0.83 3.0±0
Rat MBP 250 12.5 8/9 12.2 ± 0.70 2.6 ± 0.62
100 5.0 8/9 14.4 ± 0.74 1.4 ± 0.51
50 2.5 0/5 - -506
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(Table 111), suggesting that the determinant they recognize may have been
destroyed by cleavage events.
The majority of the hybrids (22 of 30) responded to both GP MBP and the
68-88 peptide with varying degrees of crossreactivity on rat and rabbit MBPs,
enabling us to group these hybrids into three setsofresponse patterns, illustrated
in Fig. 2, B-D. Although each pattern gave maximal responses to GP MBP at
concentrations between 0.3 and 0.03 nmol/ml, only pattern 68-88.1 displayed
similar sensitivity to the GP 68-88 peptide and rat MBP. This was also the only
pattern to display a moderate response to rabbit MBP. Pattern 68-88.2 required
up to 50 times more GP 68-88 peptide and ^-1,000 times more rat MBP toHAPP AND HEBER-KATZ
TABLE III
Response of GP MBPNon-68-88-reactive Hybrids to 3
nmol* GP Fragment/ml
* 3 nmol/ml, 50 ug GP MBP/ml; 11 ug, 1-37/ml; 13 fag, 43-88/ml ; 24
rug, 89-169/ml.
$ The proliferative response of the IL-2-dependent line HT2 when cul-
tured with supernatant from GP MBP-induced T cell hybridomas as-
sayedforresponse to the GP MBPfragmentsdescribedabove. Underlin-
ingindicates positive results.
TABLE IV
Summary ofFine Specificities of GP MBP-inducedHybridomas
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induce the same level ofstimulation as GP MBP, while pattern 68-88.3 required
1,000 times more rat MBP or GP 68-88 peptide to induce the same level of IL-
2 production as 0.003 nmol/ml of GP MBP. Table IV summarizes the distribu-
tion ofthe various reactivity patterns among the hybrids. Patterns 68-88.1, 68-
88.2, and 68-88.3 appear almost equally among the 68-88-specific hybrids.
The Clonal Response to Rat MBP.
￿
Of 15 hybrids generated from rat MBP-
immune animals (two different fusions), 8 hybrids responded to the 68-88
determinant ofGP MBP (Fig. 3A) and all ofthese possessed a reactivity pattern
of68-88.1. Not surprisingly, this was the pattern displaying the best reactivity
to rat MBP (equipotent with GP MBP).
The remaining seven hybrids displayed equal reactivity to a non-68-88
determinant of GP, rat, rabbit, and pig MBPs (Fig. 3B). This pattern was absent
among the GP MBP-induced hybrids. To localize this determinant, we tested
six ofthese hybrids with the cleavage fragments ofGP MBP. Fourofthe hybrids
responded only to the 89-169 fragment, one only to the 1-37 fragment and
one to none of the fragments (Table V). Table VI compares the reactivity
patterns of all of the rat MBP-induced hybrids to those of GP MBP-induced
hybrids.
Encephalitogenicity ofNon-68-88 Determinants.
￿
To determine if the non-68-
88 specificities could contribute to the development of EAE, we developed
Hybridoma GP MBP 1-37 43-88 68-88 89-169
cpM x 10-s
MC6.1 _48$ 3 2 2 3
M4.20 81 1 2 3 2
MK5.1 50 2 2 2 1
M3 .34 _82 4 3 1 1
MH12.1 _97 8 5 7 3
M3 .35 _83 6 80 6 6
M2.56 25 3 44 2 2
Specificity pattern Number of
hybrids
Percent of
total
Non-68-88, GP only 8 26
68-88.1 7 24
68-88.2 8 26
68-88.3 7 24508
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3 0.3 0.03 0.003
Ag concentration nmoUml
TABLE V
Response ofRatMBPNon-68-88-reactive Hybridomas to 0.3
nmol* GP Fragment/ml
FIGURE 3.
￿
(A-B) Proliferative response of the IL-2-de-
pendent line HT2 when cultured with supernatant from
rat MBP-inducedT cell hybridomas assayed forresponse
to GP MBP (9), the 68-88 peptide of GP MBP (p), rat
MBP (A), rabbit MBP (/), and pig MBP (El). Each data
point is the average of triplicate wells. (A) Hybridoma
RI.104, representative of the 68-88.1 pattern; (B) hy-
bridoma R2.8,representative of thespeciescrossreactive,
non-68-88 pattern.
* 0.3 nmol/ml, 5 gg GP MBP/ml; 1.1 jug, 1-37/ml; 1.3 kg, 43-88/ml ; 2.4 tag,
89-169/ml.
$ The proliferativeresponse of theIL-2-dependent line HT2 when cultured with
supernatant from rat MBP-induced T cell hybridomas assayed for response to
theGP MBP fragmentsdescribed above.
specific short-term T cell lines and used them to adoptively transfer EAE. The
lymph node cells from a single rat immunized with 500 ug of rat MBP were
divided into two equal aliquots. One was stimulated in vitro three times with 5
ug GP 68-88/ml and the other was cultured in parallel with 40 Ag of pig
MBP/ml. These two antigens were chosen because hybrids specific for the 68-
88 determinant never showed crossreactions on pig MBP, while all of the
crossreactive non-68-88-specific hybrids induced by immunization with rat
MBP reacted well to pig MBP. The two different lines displayed mutually
exclusive reactivities as shown in Fig. 4 after three rounds of in vitro stimulation.
At this time, they were tested for their ability to transfer EAE to naive syngeneic
Hybridoma GP MBP 1-37 43-88 68-88 89-169
cpm x 10-'
R2.8 59$ 11 12 8 54
R2.42 106 3 6 5 32
R1.106 74 15 15 9 64
R2.34 T3 _ 10 16 1 50
R2.10 103 9 12 7 5
R1 .99 122 58 4 11 170
80 r-
60
x 40
E n
20
TABLE VI
Summary ofFine Specicities of Rat MBP-inducedHybridomas and Comparison
to GP MBP-induced Hybridomas
A
￿
Pig MBP-Selected
B
￿
GP 88-88-Selected
3 0.3 0.03 0.003
Ag concentration nmol/mi
In vitrostimulant
GP 68-88
Pig MBP
HAPP AND HEBER-KATZ
FIGURE 4.
￿
(A and B) Proliferative response of T cell
linesgeneratedfrom arat MBP-immunized animal. One
subline was raised against pig MBP (A) and the other
against the 68-88 peptideof GP MBP (B). Proliferation
wasmeasured at thetime ofthethirdin vitrostimulation.
Theantigens used were rat MBP("), the 68-88 peptide
of GP MBP (O), pigMBP (/), and PPD(0).
TABLE V11
Adoptive Transfer of EAE by Short-term T Cell Linesfrom RatMBP-immunizedDonors
* Cells were harvested 3 d after the third in vitro stimulation, washed, and administered
intravenously in saline; recipients were given 350 red whole-body irradiation immediately
before transfer.
Average day of onset indicates the average number of days ± SD before the appearance of
the first clinical symptom.
§ Clinical symptoms were scored as follows: 1, floppy tail; 2, partialparalysisof the hind limbs;
3, full paralysis ofboth limbs; 4, full paralysis of the fore andhind limbs.
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GP MBP-induced Rat MBP-induced
Specificity pattern Number of
hybrids
Percent of
total
Number of
hybrids
Percent of
total
Non-68-88, GP only 8 26 - -
Non-68-88, crossreactive 0 0 8 53
68-88.1 7 24 7 47
68-88.2 8 26 0 0
68-88.3 7 24 0 0
Cell number
transferred*
No.
sick/total x Dayoftonset z Maximuml clini-
calsymptom
15 x 106 3/3 4.3 ± 0.57 3.0 ± 0
3 x 106 3/3 6.0±0 2.7±0.57
15 x 106 3/3 5.0 t 0 3.0 ± 0
3 x 106 3/3 5.7 t 0.57 2.0 t 0510
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recipients. As illustrated in Table VII, both T cell lines were able to transfer
clinical symptoms of EAE in a dose-dependent fashion .
Discussion
We began these studies by asking why GP MBP is so much more potent than
rat MBP at causing EAE in Lewis rats. This is especially important, considering
that it is rat MBP that is seen in vivo and its recognition is most likely responsible
for disease. We expected that the difference between these two MBPs seen in
disease induction would also be reflected in the antigenic potency of these
molecules for T helper cell populations which both proliferate and produce IL-
2 in response to antigen, since it is these populations that have been shown to
transfer disease. In fact, in support of this notion, previous studies by Kibler et
al. (8) had shown that immunization of Lewis rats with the rat MBP 68-88
peptide cleavage fragment resulted in a proliferative T cell response that at the
whole population level was greater to GP fragment than to rat MBP fragment.
Thus, we proposed a model in which GP MBP and rat MBP induced the same
population of disease-causing T cells with a higher affinity for GP MBP than for
rat MBP, and therefore a lower concentration of GP MBP than of rat MBP
would be needed to give the same level of disease.
To resolve this at the clonal level, we made T cell hybridomas from immunized
Lewis rats. Animals immunized with GP MBP, the heterologous antigen, gener-
ated a large number of T cell clones (75%) that reacted to GP MBP, rat MBP,
and the encephalitogenic determinant, 68-88. Two-thirds of the 75% were more
reactive to GP MBP than to rat MBP, as we predicted. Interestingly, one-third
of the 75% reacted equally well to GP MBP and to rat MBP. Thus, GP MBP
was not only good at inducing T cells with anti-rat MBP reactivity but could also
induce highly reactive rat MBP-specific T cell clones.
When we examined the rat MBP-immunized Lewis rats, we found a picture
very different from what we expected . All of the T cell hybridomas were high
responders to rat MBP and these were of two major specificities. Half of the
hybridomas were reactive to 68-88, equally reactive to GP and rat MBP, and
had the same antigen concentration requirements seen with the most potent
anti-rat MBP T cells from GP MGP-primed animals. The remaining 50% were
reactive to other determinants outside 68-88. Using MBP cleavage fragments,
the determinants were mapped to the 1-37 and 89-169 regions and one in a
region destroyed by pepsin cleavage (perhaps the same encephalitogenic deter-
minants at 89-115 and 37-42 previously mapped for bovine BP [18, 20]). A
clear demonstration as to the potency of these cells with such specificities was
seen in the ability of cell lines from rat MBP primed animals with the same two
specificity patterns to be highly encephalitogenic when injected into Lewis rats.
The ability of rat MBP primed T cells to respond well to rat MBP in vitro,
even to respond better to rat MBP than do GP MBP primed T cells, and to
transfer disease regardless of the specificity, does not reflect the poor immuno-
genicity of rat MBP in vivo and presents us with a paradox. A simple explanation,
however, is that differential regulation of the immune response is occurring in
vivo.
The fact that GP and rat MBPs were equally capable of stimulating the rat-HAPP AND HEBER-KATZ
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induced clonotypes indicates that therespective target determinants wereequally
antigenic on both MBPs. We feel that this indicates that both MBPs can be
processed and presented identically by APC, despite minor amino acid sequence
differences and the presence of the truncated form of rat MBP. However,
immunization with the two different MBPs induced two T cell populations
differing not only in the clonotypes that appeared, but also in the frequencies
with which they appeared, indicating that some component of the immune
system can discriminate between these two antigens. We propose here that it is
neither the T helper cell nor the APC, but must be a regulatory Tcell or MBP-
specific antibody.
Summary
We have examined the fine specificity of a panel ofcloned Tcell hybridomas
generated from Lewis rats immunized with guinea pig (GP) or Lewis rat myelin
basic protein (MBP) to determine theautoimmune Tcell repertoire thatdevelops
in experimental allergic encephalomyelitis (EAE). This analysis has demonstrated
that GP MBP, which was ^-10-fold more potent for EAE induction than the
autologous rat MBP, produced a population in which almost one-fourth of the
members responded to GP-unique determinants and displayed no crossreactivity
on the self antigen. The remaining majority of GP MBP-induced clones were
specific for the 68-88 encephalitogenic determinant and could be subdivided
into three groups based on their varying responses to the 68-88 peptide and rat
and rabbit MBPs. Surprisingly, one of these groups showed equal reactivity to
GP and rat MBPs.
In contrast, the clonotype composition of the Tcell population induced by rat
MBP was quite different. One-half of these clones comprised a single group
responding to the 68-88 determinant, reacting equally with GP and rat MBP.
All ofthese responded to the same range ofantigen concentrations as their GP-
induced counterparts. The remaining halfof that population contained a collec-
tion of clones that was nearly as encephalitogenic as the 68-88 population after
propagation as a short-term T cell line. These clones were specific for at least
three distinct antigenic determinants, all displaying extensive cross-species reac-
tivity, and required as little or less rat MBP for maximal stimulation as did the
68-88-reactive clones. We therefore conclude that the T cell repertoire for
MBP does include clones with reactivity to both 68-88 and non-68-88 deter-
minants ofGP and rat MBPs, and that both MBPs appear to be equally capable
of stimulating these clones in vitro. However, the differences in the clonotype
composition ofthe populations induced by immunization with these twoantigens
suggest that rat and GP MBPs are subject to different immunoregulatory con-
straints in the animal and may account for the difference in the encephalitogenic
potential of these two antigens.
Receivedfor publication 25 September 1987.
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